Location: Home
  • search
  • go
  • Relate News
  • 6/21/2024CDE Issues the Technical Guidelines for Clinical Trial of Viral Infect...
  • 6/21/2024CDE Solicits Comments on the Technical Guidelines for Non-Clinical Stu...
  • 6/21/2024Chinas NMPA Meets US Counterpart in First High-level Meeting at FDA HQ...
  • 6/21/2024Lecheng Pilot Project Marks 5th Anniversary with Focus on Advancing Re...
  • 6/21/2024Recent Official and Executive Moves
  • 6/21/2024Drug R&D and Product Registration News Digest June 2024 (3)
  • 6/20/2024Fosun to Reduce Its Stake in India's Gland Pharma
  • 6/20/2024Biocon Eyes China for Generic Diabetes and Weight-Loss Drug Trials
  • 6/20/2024Cheaper Versions of Blockbuster Obesity Drugs Are Being Created in Ind...
  • 6/19/2024Big Changes to China's BMI System Expected at 3rd Plenum (Pekingnology...
  • 6/19/2024Day One Biopharma Nabs ex-China Rights of MabCare's ADC MTX-13
  • 6/19/2024China Made Advances in Pharma Innovation and Quality: NMPA Official
  • 6/19/2024Tencent Bets on China Healthcare as Needs Grow
  • 6/19/2024China Allocates More Urban Medical Resources to Lower-level Healthcare...
  • 6/18/2024RecoRNA Biotechnology and Starna Therapeutics Enter Strategic Partners...
  • 6/18/2024CDE Solicits Comments on the Technical Requirements for the Pharmaceut...
  • 6/18/2024China Biopharma Tracker – May 2024 (PharmaDJ)
  • 6/17/2024FDA Halts MediLink-BioNTech's ADC Trial After Three Fatalities
  • 6/17/2024CDE Issues the List of Reference Formulations for GQCE Studies (81st B...
  • 6/17/2024CDE Solicits Comments on the Guidelines for Clinical Trial Design of N...
  • 6/17/2024NMPA Announces Package Insert Revision of Cyclophosphamide Adenosine, ...
  • 6/14/2024Takeda, Ascentage Enter into Global License Deal for Olverembatinib
  • 6/14/2024CDE Issues Two Pharmaceutical Change Research Guidelines
  • 6/14/2024CDE Issues the Dossier Requirements for Marketing Registration Applica...
  • 6/14/2024CDE Issues the Technical Guidelines for the Assessment of Adverse Even...
  • 6/14/2024Recent Official and Executive Moves
  • 6/14/2024Livzon Seeks Approval for Generic Version of Novo Nordisk's Ozempic
  • 6/14/2024Drug R&D and Product Registration News Digest June 2024 (2)
  • 6/14/2024In Depth: How China's Pricing Regime Penalizes Innovative Drugmakers (...
  • 6/13/2024CDE Issues the Technical Guidelines for Post-Marketing Pharmaceutical ...
  • Page:4/718 Total number of articles:21530: [First][<<] [2] [3] [4] [5] [6] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group